You will receive a reminder email the day before the event.
Monday, October 23, 2017
Marriott Marquis Washington, DC
Marquis Ballroom Salon 6 - 10 Meeting Level 2
Washington, DC
CREDITS AVAILABLE:
Maximum Of 1.5 AMA PRA Category 1 Credit(s)™
In this symposium, participants will have unique opportunities to interact with leading experts on the practical challenges of diagnosis, treatment, and management of nonalcoholic steatohepatitis (NASH), a growing epidemic in the United States and the most common form of chronic liver disease worldwide. Highlights of the symposium will include the current status of emerging therapies and how they may fit into the multidisciplinary approach to the management of patients with NASH.
Professor of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri
Associate Professor of Medicine, NAFLD Clinical Research Program, Division of Gastroenterology/Hepatology, Duke Univeristy, Durham, North Carolina
Professor of Medicine; Chief, Division of Endocrinology, Diabetes, and Metabolism, The University of Florida, Gainesville, Florida
This activity is intended for hepatologists, gastroenterologists, diabetologists, endocrinologists, and primary care physicians.
The goal of this activity is to increase participants' competence in the evaluation, diagnosis, and treatment of patients with nonalcoholic steatohepatitis (NASH).
Upon completion of this activity, participants will
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Presented for attendees of the 68th AASLD Annual Meeting. This event/function is sponsored by Medscape Education and supported by Intercept Pharmaceuticals, Inc. This is not an official function/event of the American Association for the Study of Liver Diseases.
Marquis Ballroom Salon 6 - 10 Meeting Level 2
901 Massachusetts Ave NW, Washington, DC 20001